The perspectives of physicians regarding antidiabetic therapy de‐intensification and factors affecting their treatment choices—A cross‐sectional study-Reference-Cited by-同舟云学术

The perspectives of physicians regarding antidiabetic therapy de‐intensification and factors affecting their treatment choices—A cross‐sectional study

Published:2020-09-03 Issue:1 Volume:75 Page:
ISSN:1368-5031
Container-title:International Journal of Clinical Practice
language:en
Short-container-title:Int J Clin Pract

Author:

Naser Abdallah Y.¹^ORCID,Alsairafi Zahra²,Alwafi Hassan³⁴,Mohammad Turkistani Fawaz⁵,Saud Bokhari Nedaa⁵,Alenazi Badi⁶,Zmaily Dahmash Eman¹,Alyami Hamad S.⁷

Affiliation:

1. Department of Applied Pharmaceutics and Clinical Pharmacy Faculty of Pharmacy Isra University Amman Jordan

2. Department of Pharmacy Practice Kuwait University Kuwait Kuwait

3. Faculty of Medicine Umm Alqura University Mecca Saudi Arabia

4. Research Department of Practice and Policy UCL School of Pharmacy London UK

5. Al Noor Specialist hospitalMinistry of Health Mecca Saudi Arabia

6. Paediatric Department Alyamamah hospital Riyadh Saudi Arabia

7. Department of Pharmaceutics College of Pharmacy Najran University Najran Saudi Arabia

Publisher

Hindawi Limited

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ijcp.13662

Reference44 articles.

1. Type 2 Diabetes Mellitus in Saudi Arabia: Major Challenges and Possible Solutions

2. Blood Glucose Control and Microvascular and Macrovascular Complications in Diabetes

3. Loss of glycemic control in patients with type 2 diabetes mellitus who were receiving initial metformin, sulfonylurea, or thiazolidinedione monotherapy;Riedel AA;Pharma,2007

4. Glycemic Control With Diet, Sulfonylurea, Metformin, or Insulin in Patients With Type 2 Diabetes MellitusProgressive Requirement for Multiple Therapies (UKPDS 49)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Health-Related Quality of Life of Patients with Type 2 Diabetes in Saudi Arabia;Patient Preference and Adherence;2022-05